X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA PANACEA BIOTECH ELDER PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x -0.2 84.6 - View Chart
P/BV x 0.1 1.9 5.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
PANACEA BIOTECH
Mar-14
ELDER PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs380149 255.5%   
Low Rs18882 228.4%   
Sales per share (Unadj.) Rs491.284.1 583.8%  
Earnings per share (Unadj.) Rs-3.2-18.3 17.4%  
Cash flow per share (Unadj.) Rs14.4-6.7 -215.1%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.583.7 449.8%  
Shares outstanding (eoy) m20.5461.25 33.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.61.4 42.1%   
Avg P/E ratio x-89.3-6.3 1,414.8%  
P/CF ratio (eoy) x19.7-17.2 -114.3%  
Price / Book Value ratio x0.81.4 54.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8337,074 82.5%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2,1791,449 150.4%   
Avg. sales/employee Rs ThNM1,874.1-  
Avg. wages/employee Rs ThNM527.0-  
Avg. net profit/employee Rs ThNM-407.7-  
INCOME DATA
Net Sales Rs m10,0895,154 195.8%  
Other income Rs m257100 257.1%   
Total revenues Rs m10,3465,254 196.9%   
Gross profit Rs m-792-766 103.3%  
Depreciation Rs m361711 50.8%   
Interest Rs m2,7561,503 183.4%   
Profit before tax Rs m-3,653-2,881 126.8%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m3,7131,771 209.7%   
Tax Rs m12517 744.9%   
Profit after tax Rs m-65-1,121 5.8%  
Gross profit margin %-7.8-14.9 52.8%  
Effective tax rate %-3.4-0.6 587.4%   
Net profit margin %-0.6-21.8 3.0%  
BALANCE SHEET DATA
Current assets Rs m9,2403,810 242.5%   
Current liabilities Rs m9,9988,365 119.5%   
Net working cap to sales %-7.5-88.4 8.5%  
Current ratio x0.90.5 202.9%  
Inventory Days Days46156 29.7%  
Debtors Days Days6067 89.2%  
Net fixed assets Rs m10,12414,480 69.9%   
Share capital Rs m20661 335.6%   
"Free" reserves Rs m5,582903 618.1%   
Net worth Rs m7,7345,127 150.8%   
Long term debt Rs m4,8895,832 83.8%   
Total assets Rs m22,88219,433 117.7%  
Interest coverage x-0.3-0.9 35.5%   
Debt to equity ratio x0.61.1 55.6%  
Sales to assets ratio x0.40.3 166.3%   
Return on assets %11.82.0 598.7%  
Return on equity %-0.8-21.9 3.9%  
Return on capital %22.33.6 613.5%  
Exports to sales %3.024.5 12.4%   
Imports to sales %0.410.2 4.2%   
Exports (fob) Rs m3071,264 24.3%   
Imports (cif) Rs m43525 8.2%   
Fx inflow Rs m3071,539 19.9%   
Fx outflow Rs m125942 13.3%   
Net fx Rs m181597 30.4%   
CASH FLOW
From Operations Rs m11,754599 1,961.6%  
From Investments Rs m-561-438 128.0%  
From Financial Activity Rs m-6,762-303 2,234.6%  
Net Cashflow Rs m4,432-141 -3,136.4%  

Share Holding

Indian Promoters % 39.6 74.5 53.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 0.6 1,250.0%  
FIIs % 16.8 1.3 1,292.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 23.6 153.0%  
Shareholders   16,479 10,259 160.6%  
Pledged promoter(s) holding % 77.6 35.1 221.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   AUROBINDO PHARMA  MERCK LTD  NOVARTIS  FULFORD INDIA  ORCHID PHARMA LTD  

Compare ELDER PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS